GLP-1 pills are coming, and they could revolutionize weight-loss
Sep 17, 2024 · Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. But she and other doctors also warn about the potential for misuse, a...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
May 21, 2024 · CNN — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
In a phase 2 trial of people who were overweight or had obesity, Boehringer Ingelheim’s survodutide, which uses both GLP-1 and glucagon, led to weight loss of 19% at 46 weeks.
FDA clarifies policies for compounders as national GLP-1 supply …
The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has been in...
Victoza: Generic GLP-1 Drug Similar to Ozempic Now Available - Healthline
Jul 3, 2024 · A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
Aug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
The Crackdown on Compounded GLP-1 Meds Has Begun
Oct 10, 2024 · This hawkish legal strategy indicates that a new phase of the GLP-1 gold rush has begun—a crackdown against any entity selling non-name-brand medications.
(JUNE 23, 2024) – Findings from three studies showcase new data on the latest developments in drug therapy innovations to treat obesity including new insights on GLP-1 (Glucagon-like peptide-1) receptor agonists.
A New Ozempic? What to Know About Experimental GLP-1 Drug - Healthline
Mar 1, 2024 · An experimental GLP-1 weight loss drug developed by Viking Therapeutics showed promising results in a mid-stage clinical trial. The drug is a dual GLP-1/GIP receptor agonist, which like...
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t
Oct 9, 2024 · Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.